SCHEMBL8012102

SCHEMBL8012102

O=C(c1ccccc1)N(C(=O)c1ccc2ccccc2c1)c1cc[c]cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.49
ESR2 Q92731 1/20 0.49
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
PLAU P00749 1/20 0.42
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
ALDH1A1 P00352 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
KDM4E B2RXH2 1/20 0.41
EGFR P00533 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
JAK1 P23458 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7831912 0.86 RAB9A (0.42) CES2CES1KMT2AALDH1A1SMN1; SMN2
SCHEMBL8016038 0.84 ESR1 (0.43) ESR1ESR2CES2CES1PLAU
SCHEMBL8010469 0.82 ESR1 (0.52) ESR1ESR2CES2CES1PLAU
SCHEMBL8010344 0.81 SMN1; SMN2 (0.43) ESR1ESR2CES2CES1ALDH1A1
SCHEMBL28075002 0.81 L3MBTL1 (0.44) CES2CES1KMT2AALDH1A1SMN1; SMN2
SCHEMBL8000574 0.76 CES2 (0.38) CES2CES1MEN1KMT2AALDH1A1
SCHEMBL5670293 0.75 PLAU (0.59) ESR1ESR2CES2CES1PLAU
SCHEMBL10588465 0.73 ESR1 (0.49) ESR1ESR2CES2CES1PLAU
SCHEMBL10937900 0.73 L3MBTL1 (0.53) CES2CES1KMT2AALDH1A1SMN1; SMN2
SCHEMBL27443700 0.73 ESR1 (0.78) ESR1ESR2CES2CES1PLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1066729-C Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-06-06 CN disclosed
CN-1060173-C Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 2001-01-03 CN disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
CN-1157288-A Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-08-20 CN disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
CN-1118781-A Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 1996-03-20 CN disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed